Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A
about
Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol A as a case studyHormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responsesThe estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesityBisphenol-A and the great divide: a review of controversies in the field of endocrine disruptionDoes rapid metabolism ensure negligible risk from bisphenol A?How should the completeness and quality of curated nanomaterial data be evaluated?Environmental endocrine disruptors: Effects on the human male reproductive systemUsing systematic reviews for hazard and risk assessment of endocrine disrupting chemicalsBisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A SubstitutesTransfer of bisphenol A from thermal printer paper to the skinA proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicalsClarity in the face of confusion: new studies tip the scales on bisphenol A (BPA)Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population?Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposureThe bisphenol A experience: a primer for the analysis of environmental effects on mammalian reproductionConsortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol AQualichem in vivo: a tool for assessing the quality of in vivo studies and its application for bisphenol APeer-reviewed and unbiased research, rather than 'sound science', should be used to evaluate endocrine-disrupting chemicalsChronic high dose intraperitoneal bisphenol A (BPA) induces substantial histological and gene expression alterations in rat penile tissue without impairing erectile functionPlastics, the environment and human health: current consensus and future trendsMetabolism Disrupting Chemicals and Metabolic DisordersIs it time to reassess current safety standards for glyphosate-based herbicides?Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.Combining web-based tools for transparent evaluation of data for risk assessment: developmental effects of bisphenol A on the mammary gland as a case study.A clash of old and new scientific concepts in toxicity, with important implications for public healthNon-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case studyEndocrine Disruption of Vasopressin Systems and Related BehaviorsOral Bisphenol A (BPA) given to rats at moderate doses is associated with erectile dysfunction, cavernosal lipofibrosis and alterations of global gene transcriptionBiomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A.Is it time to end concerns over the estrogenic effects of bisphenol A?Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals?Assessing toxicological data quality: basic principles, existing schemes and current limitations.Estrogens of multiple classes and their role in mental health disease mechanisms.Estrogenic activity of bisphenol A and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles.Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure.The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-AnalysisEnhancing credibility of chemical safety studies: emerging consensus on key assessment criteriaBurrowing in the freshwater mussel Elliptio complanata is sexually dimorphic and feminized by low levels of atrazine.Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital systemAssessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity
P2860
Q24288816-220149A0-62BA-4CF2-A592-937A8A9EBC8DQ24613799-E87E1780-F14E-40F4-B8B3-333897BFA33FQ24615389-89817FF9-F1B5-4E04-9AD9-0EA1CCE0B4E7Q24648358-ECE3C9BD-17D2-4AD1-B7D5-4E8047E5ECAEQ24651317-02A3CCD4-043F-4047-AA42-2987AEFCEA58Q27908490-C12EB154-C151-4997-9DE8-1F58D25BFD63Q28070418-6F26DEE2-8B71-4B7B-8698-67DC9C5EEBFEQ28079859-32ADD0BB-57EF-4968-B293-D5E1653D1C35Q28084079-1058C2AE-007D-4A89-9849-B78AEB6B58B8Q28287658-D7EF2FA9-F114-475B-B8F0-C22FF2ED5A3EQ28384100-3817A3C4-57B1-4B54-9733-CE0DEC33C4A7Q28385033-DBC75090-DE72-4477-B209-77F8852EA490Q28387496-467CF4E7-9026-413A-8BD2-849B69E787B5Q28390400-3EA53159-F579-4929-BDFA-20A99C750829Q28391785-466A887A-3D73-4CB0-BAC2-86D771AF77D9Q28393288-1EEBE88F-D75A-4546-8DE5-74E625B822A7Q28539319-8B4A4F42-0419-458C-B012-E55E18252AADQ28559107-51044112-44E2-4C56-A7AA-DF02B611258BQ28575242-DFB27B26-0219-48A5-AE95-01A572119120Q28752073-4638BE10-308C-4782-AA5C-8636649D7E95Q29248099-51F56F0C-3566-4B7E-A0DB-20F4DB1547A0Q30235180-C3E37BBC-B439-4D85-BCC1-2D046C2614D5Q30396069-35DAA2D8-DCA0-48C4-8589-9AE07954EC68Q31119387-D44571A0-0835-458B-BC07-C418D0C90F15Q33569350-772A0F56-C825-44B5-841E-B75C14A84E21Q33676877-2875C3DC-0291-452D-9980-3BCA674B2925Q33811121-899DF922-E090-447B-83FC-A30A65F0FADAQ33903401-0894B0AD-AD6E-4D62-A647-2F5C9F24402DQ34060021-6DBE6DA8-658A-4626-8638-A12BEA6D8042Q34098085-28FBFDEF-924F-4286-A711-FA4D5EB0AC99Q34230650-6B051AAE-4E2C-43E6-8E1D-5CA6BB42F52DQ34234260-4AC66612-BEB8-4FB3-9AB9-8511114A0DC0Q34272184-02EB4992-B892-4CB2-A4B0-E118ED25985AQ34478546-3AFE8710-B78A-4BA3-8532-8E54E7A7361DQ34623620-6C25897A-54C7-40A9-8C7B-7EBEF3FCBCBBQ35012566-A420A110-85D4-479F-90BD-0339A9F27F2CQ35044720-4D444188-69A6-4F45-9AA7-F328B1FEE8BAQ35205891-8E27B107-DC7B-4651-8067-77BA4A37E327Q35317705-C916B9EF-6BBE-4FAE-BEB8-F9ED3C34A6C6Q35632704-3015BD9C-2E53-4A76-AE59-9B1802AC429A
P2860
Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: the case of bisphenol A
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Why public health agencies can ...... data: the case of bisphenol A
@ast
Why public health agencies can ...... data: the case of bisphenol A
@en
Why public health agencies can ...... data: the case of bisphenol A
@nl
type
label
Why public health agencies can ...... data: the case of bisphenol A
@ast
Why public health agencies can ...... data: the case of bisphenol A
@en
Why public health agencies can ...... data: the case of bisphenol A
@nl
prefLabel
Why public health agencies can ...... data: the case of bisphenol A
@ast
Why public health agencies can ...... data: the case of bisphenol A
@en
Why public health agencies can ...... data: the case of bisphenol A
@nl
P2093
P2860
P50
P3181
P356
P1476
Why public health agencies can ...... data: the case of bisphenol A
@en
P2093
Ana M Soto
Benson T Akingbemi
Beverly S Rubin
Carlos Sonnenschein
Cheryl S Watson
Chris E Talsness
D Andrew Crain
Francesca Farabollini
Frederick S vom Saal
Gilbert Schoenfelder
P2860
P304
P3181
P356
10.1289/EHP.0800173
P407
P577
2009-03-01T00:00:00Z